Qure.ai, a Copenhagen, Denmark and Mumbai, India and New York-based one of the leading health tech companies using artificial intelligence (AI) for medical imaging diagnostics, announced that it secured $40 million in funding.

The round was led by Novo Holdings and HealthQuad and backed by existing investors MassMutual Ventures, including Fractal Analytics and Sequoia Capital.

Qure.ai will use the new investment to expand and strengthen its global reach, particularly in the U.S. and Europe, and intensify product development for critical care and community diagnostics.

Company: Qure.ai Technologies Inc.

Raised: $40.0M

Round: Unknown

Funding Month: March 2022

Lead Investors: Novo Holdings and HealthQuad

Additional Investors: MassMutual Ventures, Fractal analytics, and Sequoia Capital

Company Website: https://qure.ai/

Software Category: AI-driven healthcare 

About the Company: Founded in 2016, Qure.ai is a pioneering artificial intelligence (AI) solutions provider that is transforming the status quo in radiology by improving imaging accuracy and improving health outcomes with machine-learning tools. Qure.ai uses deep-learning technologies to enable automated interpretation of radiology exams such as X-rays, CTs, ultrasounds, and MRI scans for medical imaging professionals who are pressed for time and resources - for faster diagnosis and faster treatment. Qure.ai is helping to make healthcare more accessible and affordable for patients worldwide. Qure.ai has carved a niche for itself with its advanced technology that reads and interprets medical images such as X-rays, CT scans, and ultrasounds in less than a minute, making equitable, high-quality healthcare a reality around the world. Qure's AI solutions are FDA-approved, CE -certified, and World Health Organization-rated.

Source: https://www.prnewswire.com/news-releases/qureai-raises-40-million-from-healthcare-investors-novo-holdings-and-healthquad-301512615.html